MedPath

Tolerance of a Calorically Dense Enteral Nutrition Formula

Completed
Conditions
Enteral Feeding
Registration Number
NCT02806427
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This prospective observational study seeks to demonstrate the ability to meet nutritional needs of a calorically dense enteral formula in critically ill patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • Adult aged > 18 years
  • Admitted to Medical ICU with expected admission of ≥ 3 days
  • Established enteral access
  • Having obtained his/her or legal representative's informed consent.
Exclusion Criteria
  • Pregnant or lactating
  • Condition which contraindicates enteral feeding (i.e. intestinal obstruction)
  • Lack of enteral access
  • Parenteral nutrition
  • Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, etc.)
  • Subject who in the Investigator's assessment cannot be expected to comply with study protocol
  • Currently participating in another conflicting clinical trial.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Daily percentage of caloric nutritional goal metFirst 3 days in the ICU
Secondary Outcome Measures
NameTimeMethod
Daily percentage of protein goal metFirst 5 days in the ICU
Adverse events and serious adverse eventsFirst 5 days in the ICU

Trial Locations

Locations (1)

OUHSC

🇺🇸

Oklahoma City, Oklahoma, United States

OUHSC
🇺🇸Oklahoma City, Oklahoma, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.